1. Home
  2. FCUV vs CASI Comparison

FCUV vs CASI Comparison

Compare FCUV & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCUV
  • CASI
  • Stock Information
  • Founded
  • FCUV 2012
  • CASI 1991
  • Country
  • FCUV United States
  • CASI China
  • Employees
  • FCUV N/A
  • CASI N/A
  • Industry
  • FCUV Industrial Machinery/Components
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • FCUV Industrials
  • CASI Health Care
  • Exchange
  • FCUV Nasdaq
  • CASI Nasdaq
  • Market Cap
  • FCUV 27.6M
  • CASI 29.0M
  • IPO Year
  • FCUV N/A
  • CASI 1996
  • Fundamental
  • Price
  • FCUV $3.67
  • CASI $1.33
  • Analyst Decision
  • FCUV
  • CASI Strong Buy
  • Analyst Count
  • FCUV 0
  • CASI 1
  • Target Price
  • FCUV N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • FCUV 15.0K
  • CASI 287.0K
  • Earning Date
  • FCUV 08-13-2025
  • CASI 08-15-2025
  • Dividend Yield
  • FCUV N/A
  • CASI N/A
  • EPS Growth
  • FCUV N/A
  • CASI N/A
  • EPS
  • FCUV N/A
  • CASI N/A
  • Revenue
  • FCUV $408,887.00
  • CASI $31,368,000.00
  • Revenue This Year
  • FCUV N/A
  • CASI N/A
  • Revenue Next Year
  • FCUV N/A
  • CASI N/A
  • P/E Ratio
  • FCUV N/A
  • CASI N/A
  • Revenue Growth
  • FCUV 6.49
  • CASI 8.39
  • 52 Week Low
  • FCUV $1.50
  • CASI $1.10
  • 52 Week High
  • FCUV $10.90
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • FCUV 40.87
  • CASI 28.60
  • Support Level
  • FCUV $3.58
  • CASI $1.10
  • Resistance Level
  • FCUV $3.78
  • CASI $2.07
  • Average True Range (ATR)
  • FCUV 0.23
  • CASI 0.28
  • MACD
  • FCUV -0.01
  • CASI -0.06
  • Stochastic Oscillator
  • FCUV 25.95
  • CASI 12.36

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: